Bliss GVS Pharma P/B Ratio
BLISSGVS • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
2.19
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
2.19
Current Price
₹252.51
Book Value/Share
₹992.73
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹1,092 Cr
Share Capital
₹11 Cr
Reserves & Surplus
₹1,040 Cr
Outstanding Shares
11,000,000
Book Value per Share
₹992.73
Valuation Signal
Signal
Fairly Valued
Historical Avg
0.14
Historical Range
0.09 - 0.18
Percentile
100.0%
Sector Context
Sector Average
-0.17
Sector Median
0.64
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Bliss GVS Pharma
- Current PB is 1464.3% above historical average
- Trading at premium to sector average PB of -0.17
P/B Ratio Historical Trend for Bliss GVS Pharma
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Bliss GVS Pharma
Additional stock information and data for BLISSGVS
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.16 | ₹992.73 | ₹163.39 | ₹1,092 | Low |
| 2024 | 0.18 | ₹911.82 | ₹164.71 | ₹1,003 | Low |
| 2023 | 0.14 | ₹917.0 | ₹124.65 | ₹917 | Low |
| 2022 | 0.09 | ₹847.0 | ₹72.40 | ₹847 | Low |
| 2021 | 0.13 | ₹828.0 | ₹103.70 | ₹828 | Low |
Sector P/B Ratio Comparison
Comparing Bliss GVS Pharma with other companies in Healthcare sector
Sector Average
-0.17
Sector Median
0.64
Lowest P/B
-11.33
Highest P/B
1.05
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -11.33 | ₹4,026 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |